Black Swift Group’s Bristol-Myers Squibb BMY Stock Holding History

Black Swift Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	17,450 -17,500	-50%	-$1.02M	0.19%	77
2025 Q4	$1.89M	Buy	+34,950	New	+$1.68M	0.31%	55
2021 Q2	–	Sell	-791	Closed	-$50K	–	93
2021 Q1	$50K	Hold	791	–	–	0.02%	110
2020 Q4	$49K	Hold	791	–	–	0.03%	90
2020 Q3	$48K	Sell	791 -1,000	-56%	-$60.2K	0.02%	75
2020 Q2	$105K	Hold	1,791	–	–	0.08%	60
2020 Q1	$100K	Buy	+1,791	New	+$109K	0.1%	44

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Black Swift Group's BMY Position: Q1 2026 in Review

Black Swift Group reduced its Bristol-Myers Squibb (BMY) stake by 50% in Q1 2026, selling an estimated $1.02M and leaving 17,450 shares worth $1.06M. The position accounts for 0.19% of the portfolio, ranked #77.

Black Swift Group first reported a position in BMY in Q1 2020 and has held it in 7 quarters since. The position peaked at $1.89M in Q4 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Black Swift Group held 17,450 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
Black Swift Group sold 17,500 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.02M.
Bristol-Myers Squibb made up 0.19% of Black Swift Group's portfolio in Q1 2026, its #77 holding.
Black Swift Group first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 7 quarters since.
Black Swift Group's Bristol-Myers Squibb position peaked at $1.89M in Q4 2025.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Black Swift Group's 13F filing for Q1 2026, filed 24 Apr 2026.